Zosano Pharma, Inc. Appoints Nandan Oza as Chief Operations Officer
5/14/2013 7:19:50 AM
More...
|
Zosano Pharma, Inc. Expands Board of Directors with Addition of Kleanthis G. Xanthopoulos, Ph.D.
4/15/2013 10:12:53 AM
More...
|
Zosano Pharma, Inc. Announces Key Strategic Hire
4/9/2013 9:21:30 AM
More...
|
Zosano Pharma, Inc. and Asahi Kasei Pharma (AHKSY.PK) Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone(TM) (teriparatide acetate)
10/10/2011 7:26:09 AM
More...
|
Zosano Pharma, Inc. to Present at the 14th Annual Drug Delivery Partnerships Meeting
1/20/2010 10:25:00 AM
More...
|
Zosano Pharma, Inc. Announces Publication of Positive Phase 2 Study of Its ZP-PTH Patch for Osteoporosis Therapy
11/9/2009 9:33:48 AM
More...
|
Zosano Pharma, Inc. to Provide Pipeline Updates at the 2009 AAPS Annual Meeting
11/2/2009 9:36:15 AM
More...
|
Zosano Pharma, Inc. Secures $30 Million in New Round of Financing
7/8/2009 6:51:51 AM
More...
|
Zosano Pharma, Inc. Announces Appointment of Thorsten von Stein as Chief Medical Officer
6/11/2009 9:56:04 AM
More...
|
Zosano Pharma, Inc. Presents Positive Phase 2 Results of Its Needle-Free Osteoporosis Therapy
4/6/2009 10:49:27 AM
More...
|
|